Article Text

PDF

Malignant mesothelioma
  1. MARTIN F MUERS
  1. Department of Respiratory Medicine
  2. Leeds General Infirmary, Leeds LS1 3EX, UK
  3. MRC Clinical Trials Unit
  4. 222 Euston Road, London NW1 2DA, UK
    1. DAVID J GIRLING
    1. Department of Respiratory Medicine
    2. Leeds General Infirmary, Leeds LS1 3EX, UK
    3. MRC Clinical Trials Unit
    4. 222 Euston Road, London NW1 2DA, UK

      Statistics from Altmetric.com

      We wish to suggest a minor correction to the otherwise excellent editorial by Drs Steele and Rudd in your recent issue.1 The status of the forthcoming British Thoracic Society study of the management of malignant mesothelioma is that this study is being supported by the British Thoracic Society and the pilot study is being assisted by the Clinical Trials Unit of the Medical Research Council. Funding for the work of the Medical Research Council Staff has been obtained through the BTS Scientific Committee and from two independent mesothelioma charities—The June Hancock Mesothelioma Research Fund and the Anthony Farmer Mesothelioma Research Fund.

      We have approached the Medical Research Council with a bid for full funding of the final study but the outcome of the application is not yet known.

      References

      View Abstract

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.